TAK1 regulates SCF expression to modulate PKBα activity that protects keratinocytes from ROS-induced apoptosis

Cell Death and Differentiation

Volumn 18, Issue 7, 2011, Pages 1120-1129

  Lam, C R I ^a   Tan, M J ^a   Tan, S H ^a   Tang, M B Y ^b   Cheung, P C F ^a   Tan, N S ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NATIONAL SKIN CENTRE   (Singapore)

Author keywords

autocrine; protein kinase B; reactive oxygen species; stem cell factor

Indexed keywords

JANUS KINASE; PROTEIN; PROTEIN C KIT; PROTEIN KINASE B; PROTEIN KINASE B ALPHA; REACTIVE OXYGEN METABOLITE; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANOIKIS; APOPTOSIS; ARTICLE; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; HUMAN; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFLAMMATION; WOUND HEALING;

APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; KERATINOCYTES; MAP KINASE KINASE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-KIT; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STEM CELL FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79958856131     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2010.182     Document Type: Article

References (39)

1. Albanesi C, Pastore S. Pathobiology of chronic inflammatory skin diseases: interplay between keratinocytes and immune cells as a target for anti-inflammatory drugs. Curr Drug Metab 2010; 11: 210-227.
2. Pierce GF. Inflammation in nonhealing diabetic wounds: the space-time continuum does matter. Am J Pathol 2001; 159: 399-403. (Pubitemid 32751068)
3. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, apoptosis. Free Radic Biol Med 2010; 48: 749-762.
4. Roy S, Khanna S, Nallu K, Hunt TK, Sen CK. Dermal wound healing is subject to redox control. Mol Ther 2006; 13: 211-220. (Pubitemid 41763500)
5. D'Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007; 8: 813-824. (Pubitemid 47462134)
6. Novo E, Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2008; 1: 5.
7. Omori E, Matsumoto K, Sanjo H, Sato S, Akira S, Smart RC et al. TAK1 is a master regulator of epidermal homeostasis involving skin inflammation and apoptosis. J Biol Chem 2006; 281: 19610-19617. (Pubitemid 44035464)
8. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 2005; 6: 1087-1095. (Pubitemid 41541786)
9. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999; 398: 252-256.
10. Tan SH, Pal M, Tan MJ,Wong MHL, Tam FU, Teo JWT et al. Regulation of cell proliferation and migration by TAK1 via transcriptional control of von Hippel-Lindau tumor suppressor. J Biol Chem 2009; 284: 18047-18058.
11. Chong HC, Tan MJ, Philippe V, Tan SH, Tan CK, Ku CW et al. Regulation of epithelialmesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing. J Cell Biol 2009; 184: 817-831.
12. Page A, Navarro M, Gaŕn M, Pé rez P, Casanova ML, Moreno R et al. IKKbeta leads to an inflammatory skin disease resembling interface dermatitis. J Invest Dermatol 2010; 130: 1598-1610.
13. Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 2002; 417: 861-866. (Pubitemid 34670334)
14. Sayama K, Hanakawa Y, Nagai H, Shirakata Y, Dai X, Hirakawa S et al. Transforming growth factor-beta-activated kinase 1 is essential for differentiation and the prevention of apoptosis in epidermis. J Biol Chem 2006; 281: 22013-22020. (Pubitemid 44181905)
15. Omori E, Morioka S, Matsumoto K, Ninomiya-Tsuji J. TAK1 regulates reactive oxygen species and cell death in keratinocytes, which is essential for skin integrity. J Biol Chem 2008; 283: 26161-26168.
16. Carroll JM, Albers KM, Garlick JA, Harrington R, Taichman LB. Tissue- and stratumspecific expression of the human involucrin promoter in transgenic mice. Proc Natl Acad Sci USA 1993; 90: 10270-10274. (Pubitemid 23328294)
17. Thrash BR, Menges CW, Pierce RH, McCance DJ. AKT1 provides an essential survival signal required for differentiation and stratification of primary human keratinocytes. J Biol Chem 2006; 281: 12155-12162. (Pubitemid 43855479)
18. Lev S, Givol D, Yarden Y. Interkinase domain of kit contains the binding site for phosphatidylinositol 30 kinase. Proc Natl Acad Sci USA 1992; 89: 678-682.
19. Blume-Jensen P, Janknecht R, Hunter T. The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser136. Curr Biol 1998; 8: 779-782. (Pubitemid 28301165)
20. Di-Pö N, Tan NS, Michalik L, Wahli W, Desvergne B. Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 2002; 10: 721-733. (Pubitemid 35335629)
21. Taylor WE, Najmabadi H, Strathearn M, Jou NT, Liebling M, Rajavashisth T et al. Human stem cell factor promoter deoxyribonucleic acid sequence and regulation by cyclic 30,50-adenosine monophosphate in a Sertoli cell line. Endocrinology 1996; 137: 5407-5414.
22. Omori E, Morioka S, Matsumoto K, Ninomiya-Tsuji J. TAK1 regulates reactive oxygen species and cell death in keratinocytes, which is essential for skin integrity. J Biol Chem 2008; 283: 26161-26168.
23. Kamata H, Honda SI, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005; 120: 649-661. (Pubitemid 40343077)
24. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820. (Pubitemid 34000785)
25. Finkel T, Serrano M, Blasco MA. The common biology of cancer and ageing. Nature 2007; 448: 767-774. (Pubitemid 47266334)
26. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-852. (Pubitemid 36019637)
27. Morioka S, Omori E, Kajino T, Kajino-Sakamoto R, Matsumoto K, Ninomiya-Tsuji J. TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP. Cell Death Differ 2009; 28: 2257-2265.
28. Ashman LK. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 1999; 31: 1037-1051. (Pubitemid 29454545)
29. Grabbe J, Welker P, Rosenbach T, Nürnberg W, Krüger-Krasagakes S, Artuc M et al. Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells. J Invest Dermatol 1996; 107: 219-224. (Pubitemid 26254837)
30. Morita E, Lee DG, Sugiyama M, Yamamoto S. Expression of c-kit ligand in human keratinocytes. Arch Dermatol Res 1994; 286: 273-277. (Pubitemid 24124341)
31. Peters EMJ, Maurer M, Botchkarev VA, Jensen KD, Welker P, Scott GA et al. Kit is expressed by epithelial cells in vivo. J Invest Dermatol 2003; 121: 976-984. (Pubitemid 37430962)
32. Shilov VN, Sergienko VI. Oxidative stress in keratinocytes as an etiopathogenetic factor of psoriasis. Bull Exp Biol Med 2000; 129: 309-313.
33. Basset-Séguin N, Escot C, Molès JP, Blanchard JM, Kerai C, Guilhou JJ. C-fos and c-jun proto-oncogene expression is decreased in psoriasis: an in situ quantitative analysis. J Invest Dermatol 1991; 97: 672-678.
34. Tovar-Castillo LE, Cancino-D́az JC, Garća-Vázquez F, Cancino-Gómez FG, León-Dorantes G, Blancas-Gonzá lez F et al. Under-expression of VHL and overexpression of HDAC-1, HIF-1alpha, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis. Int J Dermatol 2007; 46: 239-246. (Pubitemid 46390278)
35. Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005; 437: 369-375. (Pubitemid 41613493)
36. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004; 2: E7.
37. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867. (Pubitemid 36019639)
38. Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res 2010; 44: 479-496.
39. IJpenberg A, Tan NS, Gelman L, Kersten S, Seydoux J, Xu J et al. In vivo activation of PPAR target genes by RXR homodimers. EMBO J 2004; 23: 2083-2091. (Pubitemid 38737735)